GL1X · GenesisL1 explorer

Ligand · F8I

F8I · ~{N}-~{tert}-butyl-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide

F8I, ~{N}-~{tert}-butyl-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide (C21 H25 N5 O3, 395.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…

Component
F8I
Formula
C21 H25 N5 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

F8I in 2 structures; the first of them:

  • 7QUF · The STK17A (DRAK1) Kinase Domain Bound to CK156 · F8I A401 · binds LEU67, GLY68, ARG69, GLY70, ALA73, VAL75, ALA88, LYS90 and 12 more
  • 7QUF · The STK17A (DRAK1) kinase domain bound to CK156 · F8I A401 · binds LEU67, GLY68, VAL75, ALA88, LYS90, LEU138, GLU139, TYR140 and 8 more

Residues it binds most

LEU 4, ALA 4, GLY 4, GLU 4, ILE 4, VAL 4, ASP 4, LYS 4, TYR 4, ARG 3 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.